keyword
https://read.qxmd.com/read/37442428/management-of-cerebral-venous-thrombosis-in-spain-motivate-descriptive-study
#1
JOURNAL ARTICLE
C Pérez Lázaro, A López-Bravo, C Gómez-Escalonilla Escobar, C Aguirre, A de Felipe, P de la Riva, S Calleja, A Arjona, M Serrano Ponz, M P Navarro-Pérez, R Delgado-Mederos, S Bashir Viturro, L Llul, J Egido, S García Madrona, N Díez González, L Benavente-Fernández, J D de la Torre-Colmenero, H Tejada Meza, A Vesperinas-Castro, L Sánchez-Cirera, S Trillo
INTRODUCTION: Cerebral venous thrombosis (CVT) is an uncommon cause of stroke that mainly affects young adults. Early, accurate diagnosis can reduce the rate and severity of complications. OBJECTIVE: The aim of this study was to analyse the clinical characteristics, management, and treatment of CVT in different centres in Spain. METHODS: We conducted a multicentre, retrospective, descriptive study of patients hospitalised due to CVT between 2008 and 2017 at 10 Spanish centres...
April 2024: Neurología
https://read.qxmd.com/read/36849315/mesenteric-venous-thrombosis
#2
REVIEW
Pablo Demelo-Rodríguez, Lucía Ordieres-Ortega, Crhistian-Mario Oblitas
Mesenteric vein thrombosis (MVT) is a rare condition that can present acutely, subacutely, or chronically. MVT can be isolated or within a splanchnic thrombosis (spleno-porto-mesenteric). Symptomatic cases usually present as nonspecific abdominal pain, with or without signs of intestinal ischemia, and the diagnosis is usually made by imaging test (abdominal CT or MRI) in patients with high clinical suspicion. An early clinical-surgical approach is recommended to screen those patients with warning signs and who benefit from an exploratory laparotomy in addition to anticoagulant treatment, which is the cornerstone of medical treatment...
May 12, 2023: Medicina Clínica
https://read.qxmd.com/read/36646420/retinal-vein-occlusion-audit-of-a-specialized-care-program
#3
JOURNAL ARTICLE
J A Rueda-Camino, F J Gimena-Rodríguez, M A Domínguez-Sepúlveda, M Bolzoni, A I Pastor-Vivas, M Angelina-García, M D Joya-Seijo, D Trujillo-Luque, D Losada-Bayo, R Barba-Martín
BACKGROUND AND OBJECTIVES: Retinal vein occlusion (RVO) is the second most frequent cause of retinal vascular disease and is related to classic cardiovascular risk factors. A specific program was designed to detect and treat risk factors in patients with RVO. The aim of this study is to audit the results of this program. PATIENTS AND METHODS: The program consisted of a multidisciplinary clinical evaluation by the Ophthalmology and Internal Medicine Departments. All patients with RVO were screened, at minimum, for hypertension, diabetes, dyslipidemia, smoking, overweight, and antiphospholipid syndrome...
January 13, 2023: Revista Clínica Espanõla
https://read.qxmd.com/read/35618638/retinal-vein-occlusion-in-patients-under-50-years-analysis-of-vascular-risk-factors-thrombophilia-carotid-ultrasound-findings-and-uncommon-aetiologies
#4
JOURNAL ARTICLE
I Sanlés González, J J Napal Lecumberri, R Pérez-Montes, A Cerveró Varona, A Casado Rojo, J L Hernández Hernández
INTRODUTION: Retinal vein occlusion (RVO) has been related to vascular risk factors and thrombophilia. METHODS: This is a prospective cohort study of all patients diagnosed with RVO and referred to an Internal Medicine clinic of a tertiary teaching hospital during a 10-year period. Clinical, laboratory and supra-aortic trunks ultrasound variables were analysed and compared according to age. RESULTS: Some 309 patients diagnosed with RVO were included, 25 of them younger than 50 years...
August 2022: Archivos de la Sociedad Española de Oftalmología
https://read.qxmd.com/read/34565709/effects-of-the-covid-19-pandemic-on-a-cohort-of-patients-with-vein-occlusion
#5
J D García Palacios, N Puente Ruiz, J J Napal Lecumberri, J L Hernández Hernández
BACKGROUND AND OBJECTIVES: A new coronavirus disease in humans, COVID-19, caused by SARS-CoV-2, emerged in December 2019. It has been associated with the development of thrombotic phenomena. Retinal vein occlusion (RVO) is mainly a consequence of vascular risk factors (VRF). This study aimed to analyze cases of COVID-19 in a cohort of patients with RVO (Valdecilla cohort). PATIENTS AND METHODS: Between December 2008 and December 2020, 429 patients with RVO were attended to in our clinic...
December 2021: Revista Clínica Espanõla
https://read.qxmd.com/read/34511275/management-of-cerebral-venous-thrombosis-in-spain-motivate-descriptive-study
#6
JOURNAL ARTICLE
C Pérez Lázaro, A López-Bravo, C Gómez-Escalonilla Escobar, C Aguirre, A de Felipe, P de la Riva, S Calleja, A Arjona, M Serrano Ponz, M P Navarro-Pérez, R Delgado-Mederos, S Bashir Viturro, L Llul, J Egido, S García Madrona, N Díez González, L Benavente Fernández, J D de la Torre Colmenero, H Tejada Meza, A Vesperinas Castro, L Sánchez Cirera, S Trillo
INTRODUCTION: Cerebral venous thrombosis (CVT) is an uncommon cause of stroke that mainly affects young adults. Early, accurate diagnosis can reduce the rate and severity of complications. OBJECTIVE: The aim of this study was to analyse the clinical characteristics, management, and treatment of CVT in different centres in Spain. METHODS: We conducted a multicentre, retrospective, descriptive study of patients hospitalised due to CVT between 2008 and 2017 at 11 Spanish centres...
September 9, 2021: Neurología
https://read.qxmd.com/read/28991284/-thrombophilia
#7
JOURNAL ARTICLE
Abraham Majluf-Cruz
No abstract text is available yet for this article.
2017: Gaceta Médica de México
https://read.qxmd.com/read/28991278/-thrombophilia-in-mexico
#8
JOURNAL ARTICLE
Benjamín Moncada, Guillermo Ruiz-Argüelles, Olga Johnson-Ponce
No abstract text is available yet for this article.
2017: Gaceta Médica de México
https://read.qxmd.com/read/18182035/the-risk-of-first-venous-thromboembolism-during-pregnancy-and-puerperium-in-double-heterozygotes-for-factor-v-leiden-and-prothrombin-g20210a
#9
JOURNAL ARTICLE
I Martinelli, T Battaglioli, V De Stefano, D Tormene, L Valdrè, E Grandone, A Tosetto, P M Mannucci
BACKGROUND: The risk of venous thromboembolism (VTE) during pregnancy in double heterozygous carriers of factor (F) V Leiden and prothrombin G20210A is not established. Hence, whether or not these women deserve antithrombotic prophylaxis when pregnant is unknown. PATIENTS AND METHODS: In the frame of a multicenter family study, 52 double heterozygous carriers of FV Leiden and prothrombin G20210A who had remained pregnant at least once before knowledge of thrombophilia, were retrospectively investigated with respect to the occurrence of first VTE during pregnancy and puerperium...
March 2008: Journal of Thrombosis and Haemostasis: JTH
https://read.qxmd.com/read/15366233/-trombofilia-current-status
#10
JOURNAL ARTICLE
Carlos Sánchez Carpio, Eduardo Rodi, Pablo Piola, María Fernanda Piola
BACKGROUND: The trombofilia states are a special tendency to vein thrombosis that are habitually presented in young people and often they are recurrent. Their more transcendent consequences are the Lung Tromboembolismo and the Syndrome Post-trombótico. OBJECTIVES: Keeping in mind the pathologies of the clotting that can produce trombofilia states in young patients, the prevalence of these processes was evaluated in patient with post-trombotic severe syndrome...
2004: Revista de la Facultad de Ciencias Médicas
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.